• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硒酸钠特异性激活 PP2A 磷酸酶,使 tau 去磷酸化,并逆转阿尔茨海默病模型中的记忆缺陷。

Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.

机构信息

Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Royal Parade, Parkville 3010, Victoria, Australia.

出版信息

J Clin Neurosci. 2010 Aug;17(8):1025-33. doi: 10.1016/j.jocn.2010.04.020. Epub 2010 May 26.

DOI:10.1016/j.jocn.2010.04.020
PMID:20537899
Abstract

Neurofibrillary tangles composed of abnormally hyperphosphorylated tau protein are a hallmark of Alzheimer's disease (AD) and related tauopathies. Tau hyperphosphorylation is thought to promote aggregation with subsequent tangle formation. Reducing tau phosphorylation by boosting the activity of the key phosphatase/s that mediate dephosphorylation of tau could be a viable clinical strategy in AD. One of the key phosphatases implicated in regulating tau protein phosphorylation is the serine-threonine phosphatase PP2A. We have determined that sodium selenate can act as a specific agonist for PP2A, significantly boosting phosphatase activity. Acute treatment of either neuroblastoma cells or normal aged mice with sodium selenate rapidly reduced tau protein phosphorylation. Sodium selenate-treated transgenic TAU441 mice had significantly lower levels of phospho- and total tau levels in the hippocampus and amygdala compared with controls and exhibited significantly improved spatial learning and memory on the Morris Water Maze task. Sodium selenate is a specific activator of PP2A with excellent oral bioavailability, and favourable central nervous system penetrating properties. Clinical studies in patients with AD are envisaged in the near future.

摘要

神经原纤维缠结由异常过度磷酸化的 tau 蛋白组成,是阿尔茨海默病(AD)和相关 tau 病的标志。tau 过度磷酸化被认为会促进聚集,随后形成缠结。通过提高关键磷酸酶/的活性来增强 tau 的去磷酸化,从而减少 tau 的磷酸化,可能是 AD 的一种可行的临床策略。参与调节 tau 蛋白磷酸化的关键磷酸酶之一是丝氨酸-苏氨酸磷酸酶 PP2A。我们已经确定,亚硒酸钠可以作为 PP2A 的特异性激动剂,显著提高磷酸酶活性。亚硒酸钠急性处理神经母细胞瘤细胞或正常老年小鼠可迅速降低 tau 蛋白磷酸化。与对照组相比,亚硒酸钠处理的转 TAU441 小鼠在海马和杏仁核中的磷酸化和总 tau 水平明显降低,并且在 Morris 水迷宫任务中的空间学习和记忆能力显著提高。亚硒酸钠是一种具有良好口服生物利用度和良好中枢神经系统穿透特性的 PP2A 特异性激活剂。预计在不久的将来将在 AD 患者中进行临床研究。

相似文献

1
Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.硒酸钠特异性激活 PP2A 磷酸酶,使 tau 去磷酸化,并逆转阿尔茨海默病模型中的记忆缺陷。
J Clin Neurosci. 2010 Aug;17(8):1025-33. doi: 10.1016/j.jocn.2010.04.020. Epub 2010 May 26.
2
Over activation of hippocampal serine/threonine protein phosphatases PP1 and PP2A is involved in lead-induced deficits in learning and memory in young rats.过度激活海马丝氨酸/苏氨酸蛋白磷酸酶 PP1 和 PP2A 参与了幼鼠铅诱导的学习和记忆缺陷。
Neurotoxicology. 2012 Jun;33(3):370-83. doi: 10.1016/j.neuro.2012.02.014. Epub 2012 Mar 1.
3
Acetyl-L-carnitine attenuates okadaic acid induced tau hyperphosphorylation and spatial memory impairment in rats.乙酰左旋肉碱可减轻岗田酸诱导的大鼠 tau 过度磷酸化和空间记忆损伤。
J Alzheimers Dis. 2010;19(2):735-46. doi: 10.3233/JAD-2010-1272.
4
Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.tau蛋白的过度磷酸化与蛋白磷酸酶2A的甲基化减少相关。
Neurobiol Dis. 2008 Sep;31(3):386-94. doi: 10.1016/j.nbd.2008.05.013. Epub 2008 Jul 23.
5
Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models.硒酸钠减轻阿尔茨海默病模型中的 tau 病理学、神经退行性变和功能缺陷。
Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13888-93. doi: 10.1073/pnas.1009038107. Epub 2010 Jul 19.
6
Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models.硒酸钠靶向高磷酸化tau 可抑制啮齿动物模型中的癫痫发作。
Neurobiol Dis. 2012 Mar;45(3):897-901. doi: 10.1016/j.nbd.2011.12.005. Epub 2011 Dec 11.
7
Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.α1-抗糜蛋白酶是一种在阿尔茨海默病大脑中过度表达的炎症蛋白,可诱导神经元中的tau蛋白磷酸化。
Brain. 2006 Nov;129(Pt 11):3020-34. doi: 10.1093/brain/awl255. Epub 2006 Sep 20.
8
Substrate-specific reduction of PP2A activity exaggerates tau pathology.PP2A活性的底物特异性降低会加剧tau蛋白病变。
Biochem Biophys Res Commun. 2009 Feb 6;379(2):400-5. doi: 10.1016/j.bbrc.2008.12.140. Epub 2009 Jan 4.
9
Nicotine exacerbates tau phosphorylation and cognitive impairment induced by amyloid-beta 25-35 in rats.尼古丁加剧淀粉样β 25-35 诱导的大鼠 tau 磷酸化和认知障碍。
Eur J Pharmacol. 2010 Jul 10;637(1-3):83-8. doi: 10.1016/j.ejphar.2010.03.029. Epub 2010 Apr 2.
10
An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.一种基于铝的阿尔茨海默病大鼠模型表现出氧化损伤、蛋白磷酸酶2A(PP2A)活性抑制、tau蛋白过度磷酸化和颗粒空泡变性。
J Inorg Biochem. 2007 Sep;101(9):1275-84. doi: 10.1016/j.jinorgbio.2007.06.001. Epub 2007 Jun 12.

引用本文的文献

1
A Narrative Review on the Neuroprotective Effects of Selenium and Vitamin D in Alzheimer's Disease.关于硒和维生素D对阿尔茨海默病神经保护作用的叙述性综述
Biol Trace Elem Res. 2025 Aug 14. doi: 10.1007/s12011-025-04788-7.
2
Insights into targeted ferroptosis in mechanisms, biology, and role of Alzheimer's disease: an update.阿尔茨海默病中靶向铁死亡的机制、生物学及作用的研究进展:最新综述
Front Aging Neurosci. 2025 Jul 21;17:1587986. doi: 10.3389/fnagi.2025.1587986. eCollection 2025.
3
Selenium compounds for cancer prevention and therapy - human clinical trial considerations.
用于癌症预防和治疗的硒化合物——人体临床试验考量
Med Rev (2021). 2025 Jan 6;5(3):203-230. doi: 10.1515/mr-2024-0065. eCollection 2025 Jun.
4
Brain-derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia.脑源性tau蛋白用于衡量阿尔茨海默病和额颞叶痴呆的治疗效果。
Alzheimers Dement (Amst). 2025 Jun 5;17(2):e70123. doi: 10.1002/dad2.70123. eCollection 2025 Apr-Jun.
5
Targeting of PP2 A/GSK3β/PTEN Axis in Alzheimer Disease: The Mooting Evidence, Divine, and Devil.阿尔茨海默病中PP2A/GSK3β/PTEN轴的靶向作用:有争议的证据、优点与缺陷
Cell Mol Neurobiol. 2025 Apr 18;45(1):36. doi: 10.1007/s10571-025-01554-0.
6
In defence of ferroptosis.为铁死亡辩护。
Signal Transduct Target Ther. 2025 Jan 3;10(1):2. doi: 10.1038/s41392-024-02088-5.
7
Protein Phosphatase 2ACα Regulates ATR-Mediated Endogenous DNA Damage Response Against Microcephaly.蛋白磷酸酶2ACα调节ATR介导的针对小头畸形的内源性DNA损伤反应。
Mol Neurobiol. 2025 Jan;62(1):1266-1281. doi: 10.1007/s12035-024-04301-6. Epub 2024 Jul 8.
8
Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer's Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy.阿尔茨海默病诊断与治疗研究中的生物标志物及靶向小分子药物:从淀粉样病变到tau蛋白病变
Neurochem Res. 2024 Sep;49(9):2273-2302. doi: 10.1007/s11064-024-04178-w. Epub 2024 Jun 6.
9
Trace Elements in Alzheimer's Disease and Dementia: The Current State of Knowledge.阿尔茨海默病和痴呆症中的微量元素:当前知识状况
J Clin Med. 2024 Apr 19;13(8):2381. doi: 10.3390/jcm13082381.
10
Altering phosphorylation in cancer through PP2A modifiers.通过PP2A修饰剂改变癌症中的磷酸化作用。
Cancer Cell Int. 2024 Jan 6;24(1):11. doi: 10.1186/s12935-023-03193-1.